dermatology
Skin cancers

Sentinel node biopsy claims earn sharp rebuke


Claims by a Sydney dermatologist that sentinel lymph node biopsy does not deserve its status as the most powerful predictor of prognosis in cutaneous melanoma have been met with sharp rebuke. In an opinion piece in the Australasian Journal of Dermatology Dr Samuel Zagarella, a senior dermatologist at Concord Hospital, Sydney, said sentinel node biopsy ...

Already a member?

Enter your email to keep reading.


OR